Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures
Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in...
Saved in:
Published in | Journal of neuroinflammation Vol. 16; no. 1; pp. 66 - 13 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
28.03.2019
BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1742-2094 1742-2094 |
DOI | 10.1186/s12974-019-1452-1 |
Cover
Abstract | Background
Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model.
Methods
In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting.
Results
Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β.
Conclusions
Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. |
---|---|
AbstractList | Abstract Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model.BACKGROUNDMicroglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model.In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting.METHODSIn this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting.Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β.RESULTSOur results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β.Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments.CONCLUSIONSOur results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by glial cells support neuronal functions, but the related mechanisms remain vague. Our goal was to demonstrate the efficacy of IL-10 in suppressing IL-1β and in inflammasome activation in mice with epileptic seizure based on an epileptic-seizure mouse model. Methods In this study, mice in which epileptic seizures were induced by administering picrotoxin (PTX) were used as a case group, and mice injected with saline were employed as the control group. The expression of nucleic acids, cytokines, or signaling pathways was detected by reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blotting. Results Our results demonstrated that IL-10 inhibits IL-1β production through two distinct mechanisms: (1) Treatment with lipopolysaccharides (LPS) results in IL-10 overexpression in microglia and reduced NLRP3 inflammasome activity, thus inhibiting caspase-1-related IL-1β maturation; (2) next, autocrine IL-10 was found to subsequently promote signal transducer and activator of transcription-3 (STAT-3), reducing amounts of pro-IL-1β. Conclusions Our results indicate that IL-10 is potentially effective in the treatment of inflammation encephalopathy, and suggest the potential usefulness of IL-10 for treating autoimmune or inflammatory ailments. |
ArticleNumber | 66 |
Author | Zhou, Xiaolin Li, Yu Qin, Lijun Li, Dongfang Liang, Liyang Luo, Xiangyang Li, Pinggan He, Zhanwen Ma, Jiangjun Sun, Yi |
Author_xml | – sequence: 1 givenname: Yi surname: Sun fullname: Sun, Yi organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 2 givenname: Jiangjun surname: Ma fullname: Ma, Jiangjun organization: Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine – sequence: 3 givenname: Dongfang surname: Li fullname: Li, Dongfang organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 4 givenname: Pinggan surname: Li fullname: Li, Pinggan organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 5 givenname: Xiaolin surname: Zhou fullname: Zhou, Xiaolin organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 6 givenname: Yu surname: Li fullname: Li, Yu organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 7 givenname: Zhanwen surname: He fullname: He, Zhanwen organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 8 givenname: Lijun surname: Qin fullname: Qin, Lijun organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 9 givenname: Liyang surname: Liang fullname: Liang, Liyang organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 10 givenname: Xiangyang orcidid: 0000-0003-1325-3106 surname: Luo fullname: Luo, Xiangyang email: luoxy33@sina.cn organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30922332$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ustu1DAUtVARfcAHsEGR2LAJ-BHb8QYJVRRGqsQG1pbj3Ew9OPbUTirBZ_EhfFM9k1KmlWBl695zjo_vPafoKMQACL0k-C0hrXiXCVWyqTFRNWk4rckTdEJkQ2uKVXN0cD9GpzlvMGaUC_oMHTOsKGWMnqDrVZggeZi_u1ATXLlw5To35XI5qP_-VW1T7Gc7uRgqE_rSHrwZR5PjCJUp9Ruz78WhGp1Nce2dKaAKts7DdnK2yuB-zgnyc_R0MD7Di7vzDH27-Pj1_HN9-eXT6vzDZW05E1PNlTIwtB1I3Nt2UEQarlrZtT2xAmMhmQBKByOh6yy3jbGct71gbKADVw1nZ2i16PbRbPQ2udGkHzoap_eFmNbapGLMgwYqsLSqp0yVOVrWcSt4o2wvWwuc2KL1ftHazt0IvYUwJeMfiD7sBHel1_FGi4ZJRVQReHMnkOL1DHnSo8sWvDcB4pw1pRjLVrR8B339CLqJcwplVAVFSINbIUhBvTp0dG_lz2YLgCyAsoycEwz3EIL1Lj16SY8u6dG79OidqHzEsW7a77V8yvn_MunCzOWVsIb01_S_SbeTxtsY |
CitedBy_id | crossref_primary_10_20307_nps_2024_30_1_30 crossref_primary_10_3390_cosmetics7040082 crossref_primary_10_3390_ijms21207448 crossref_primary_10_3390_ijms22052573 crossref_primary_10_1016_j_peptides_2021_170581 crossref_primary_10_2174_1566524023666230731095431 crossref_primary_10_3389_fimmu_2023_1226196 crossref_primary_10_1016_j_jneuroim_2020_577343 crossref_primary_10_7717_peerj_17252 crossref_primary_10_1007_s12264_023_01170_2 crossref_primary_10_3390_biom10101437 crossref_primary_10_1002_glia_24323 crossref_primary_10_1016_j_chembiol_2021_07_014 crossref_primary_10_1016_j_jchemneu_2020_101849 crossref_primary_10_1002_cti2_1299 crossref_primary_10_1007_s00210_021_02175_2 crossref_primary_10_1007_s00109_020_01988_7 crossref_primary_10_34172_PS_2020_32 crossref_primary_10_3389_fbioe_2021_754952 crossref_primary_10_3390_ijms231810266 crossref_primary_10_1007_s11011_024_01391_y crossref_primary_10_1016_j_yebeh_2022_108615 crossref_primary_10_7554_eLife_88686_3 crossref_primary_10_1007_s10072_021_05331_x crossref_primary_10_3389_fpsyt_2023_1180929 crossref_primary_10_1016_j_eplepsyres_2022_107018 crossref_primary_10_3390_immuno2040040 crossref_primary_10_1124_jpet_120_000004 crossref_primary_10_1016_j_clim_2022_108935 crossref_primary_10_1007_s11756_021_00911_w crossref_primary_10_1016_j_jbc_2023_105205 crossref_primary_10_1186_s12974_020_01944_9 crossref_primary_10_1016_j_omtn_2023_102065 crossref_primary_10_1039_D2FO01490D crossref_primary_10_3390_biomedicines12020410 crossref_primary_10_3390_ijms251910537 crossref_primary_10_1186_s12989_024_00589_3 crossref_primary_10_3390_biomedicines11102825 crossref_primary_10_1007_s12035_024_04359_2 crossref_primary_10_14202_vetworld_2024_1655_1660 crossref_primary_10_1016_j_jneumeth_2021_109194 crossref_primary_10_1111_epi_16424 crossref_primary_10_1155_2021_7946252 crossref_primary_10_3389_fcell_2021_740758 crossref_primary_10_1021_acs_jmedchem_4c01176 crossref_primary_10_7554_eLife_88686 crossref_primary_10_3390_antiox9100970 crossref_primary_10_1016_j_brainresbull_2021_05_001 crossref_primary_10_1007_s12026_022_09286_9 crossref_primary_10_1016_j_bbi_2021_08_223 crossref_primary_10_1016_j_intimp_2025_114329 crossref_primary_10_3390_microorganisms10050911 crossref_primary_10_1016_j_intimp_2024_112386 crossref_primary_10_3136_fstr_FSTR_D_23_00246 crossref_primary_10_1111_iej_13633 crossref_primary_10_1111_epi_18038 crossref_primary_10_3389_fcell_2021_790437 crossref_primary_10_1155_2020_3649613 crossref_primary_10_18632_aging_202491 crossref_primary_10_3389_fphar_2020_00372 crossref_primary_10_1016_j_eplepsyres_2021_106588 crossref_primary_10_1039_D4BM01530D crossref_primary_10_1038_s41540_024_00473_y crossref_primary_10_1038_s41598_022_22806_9 crossref_primary_10_3390_cells12212570 crossref_primary_10_1155_2019_8928934 crossref_primary_10_3390_nano11102510 crossref_primary_10_1038_s41467_022_33542_z crossref_primary_10_1002_brb3_2011 crossref_primary_10_3390_cells10061524 crossref_primary_10_1186_s10194_021_01353_0 crossref_primary_10_1007_s11064_021_03367_1 crossref_primary_10_1172_jci_insight_178216 crossref_primary_10_2147_CMAR_S244374 crossref_primary_10_3390_biomedicines11040999 crossref_primary_10_1002_glia_24255 crossref_primary_10_1155_2021_5567046 crossref_primary_10_1007_s11064_023_03951_7 crossref_primary_10_1021_acsptsci_4c00556 crossref_primary_10_1007_s10571_023_01429_2 crossref_primary_10_1007_s11095_023_03552_7 crossref_primary_10_1186_s12883_020_01825_x crossref_primary_10_1186_s12974_020_01854_w crossref_primary_10_2147_JIR_S469451 crossref_primary_10_3390_tropicalmed9010013 crossref_primary_10_1016_j_it_2020_02_002 crossref_primary_10_3389_fvets_2023_1258244 crossref_primary_10_3389_fcell_2024_1406330 crossref_primary_10_3389_fnmol_2024_1430080 crossref_primary_10_1007_s13596_021_00573_8 crossref_primary_10_1007_s11064_021_03267_4 crossref_primary_10_18632_aging_205970 crossref_primary_10_3389_fcell_2021_630645 crossref_primary_10_3390_ijms25116078 |
Cites_doi | 10.1016/0014-2999(91)90152-G 10.1016/j.neurobiolaging.2017.08.022 10.1101/cshperspect.a022699 10.1186/s12974-016-0531-9 10.1016/j.yebeh.2015.04.063 10.1111/j.1528-1167.2005.00298.x 10.4049/jimmunol.180.12.7827 10.1038/nrneurol.2010.178 10.1038/nrn752 10.1111/epi.13100 10.1046/j.1471-4159.1994.63051872.x 10.1016/j.pharep.2014.06.005 10.1002/glia.20554 10.1186/s12974-016-0727-z 10.1016/B978-0-444-52898-8.00010-0 10.1016/j.jneuroim.2015.04.003 10.3892/ijmm.2016.2656 10.1016/S0969-9961(03)00127-X 10.1111/j.1528-1167.2010.02606.x 10.1002/jcla.20374 10.1186/s12906-018-2287-5 10.2147/IJN.S31050 10.1111/epi.12354 10.1523/JNEUROSCI.1901-08.2008 10.1038/ni.1703 10.1016/j.immuni.2010.05.007 10.1016/j.vaccine.2009.03.034 10.1002/epi4.12036 10.1016/j.yebeh.2014.04.009 10.1186/1742-2094-9-126 10.1073/pnas.1008155107 10.1007/s00018-008-8521-4 10.1021/nn404473g 10.1016/j.intimp.2014.12.035 10.1074/jbc.M607594200 10.1016/j.cyto.2015.06.017 10.1016/j.nbd.2006.06.003 10.1016/j.bbi.2008.03.009 10.1523/JNEUROSCI.19-12-05054.1999 10.1038/nrneurol.2010.17 10.1007/s12035-015-9593-4 10.1111/imr.12617 10.1007/s00281-007-0085-0 10.1016/j.nbd.2007.01.015 10.1016/j.pbb.2009.10.003 10.2174/0929867321666141106124657 10.1002/glia.23008 10.1523/JNEUROSCI.1820-08.2008 10.1038/nature10759 10.1016/j.eplepsyres.2009.09.004 10.1523/JNEUROSCI.4058-14.2015 10.1007/s13311-011-0039-z 10.3345/kjp.2013.56.7.271 10.1186/s12974-016-0546-2 10.1016/j.jneuroim.2010.05.016 10.1016/S0006-8993(02)03050-0 10.1007/s11481-009-9164-4 10.1016/j.immuni.2009.02.005 |
ContentType | Journal Article |
Copyright | The Author(s). 2019 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s). 2019 – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12974-019-1452-1 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1742-2094 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c PMC6437919 30922332 10_1186_s12974_019_1452_1 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM 7T5 7TK 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c536t-599aef8be70dc8f917a5987b8d1c6006736e22fa7ebbc5c4ac558d633f2f59453 |
IEDL.DBID | M48 |
ISSN | 1742-2094 |
IngestDate | Wed Aug 27 01:23:55 EDT 2025 Thu Aug 21 18:45:36 EDT 2025 Fri Sep 05 04:45:37 EDT 2025 Fri Jul 25 04:43:54 EDT 2025 Wed Feb 19 02:34:01 EST 2025 Tue Jul 01 02:54:30 EDT 2025 Thu Apr 24 23:10:05 EDT 2025 Sat Sep 06 07:29:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | IL-1β Epilepsy IL-10 Microglia |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-599aef8be70dc8f917a5987b8d1c6006736e22fa7ebbc5c4ac558d633f2f59453 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1325-3106 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12974-019-1452-1 |
PMID | 30922332 |
PQID | 2211408661 |
PQPubID | 55345 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c pubmedcentral_primary_oai_pubmedcentral_nih_gov_6437919 proquest_miscellaneous_2200786859 proquest_journals_2211408661 pubmed_primary_30922332 crossref_primary_10_1186_s12974_019_1452_1 crossref_citationtrail_10_1186_s12974_019_1452_1 springer_journals_10_1186_s12974_019_1452_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-03-28 |
PublicationDateYYYYMMDD | 2019-03-28 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Journal of neuroinflammation |
PublicationTitleAbbrev | J Neuroinflammation |
PublicationTitleAlternate | J Neuroinflammation |
PublicationYear | 2019 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | CA Colton (1452_CR16) 2009; 4 FJ Sun (1452_CR19) 2016; 13 M Maldonado (1452_CR5) 2003; 14 B Freche (1452_CR45) 2007; 29 IC Allen (1452_CR37) 2009; 30 AM Minogue (1452_CR34) 2012; 9 A Vezzani (1452_CR8) 2012; 107 A Vezzani (1452_CR46) 2015; 6 MA Galic (1452_CR25) 2008; 28 A Sokka (1452_CR1) 2017; 2 A Vezzani (1452_CR2) 2005; 46 A Crespel (1452_CR4) 2002; 952 E Avignone (1452_CR18) 2008; 28 JW Choi (1452_CR35) 2016; 38 T Strowig (1452_CR42) 2012; 481 A Vezzani (1452_CR9) 1999; 19 Z Xiao (1452_CR13) 2015; 282 S Auvin (1452_CR47) 2010; 51 T Takenouchi (1452_CR28) 2008; 180 VH Perry (1452_CR15) 2010; 6 K Riazi (1452_CR24) 2010; 89 L Franchi (1452_CR43) 2009; 10 SL Demento (1452_CR41) 2009; 27 TD Kanneganti (1452_CR38) 2006; 281 MY Huang (1452_CR27) 2018; 18 S Gordon (1452_CR17) 2010; 32 PF Fabene (1452_CR21) 2010; 224 B Steinborn (1452_CR10) 2014; 66 V Sackmann (1452_CR55) 2017; 60 KI Strauss (1452_CR48) 2016; 13 E Kosonowska (1452_CR23) 2015; 49 M Maroso (1452_CR53) 2011; 8 S Singh (1452_CR29) 2010; 94 TL Gouveia (1452_CR59) 2014; 36 A Moquin (1452_CR26) 2013; 7 SM Kamal (1452_CR31) 2012; 7 ML Diamond (1452_CR14) 2015; 56 JG Sheng (1452_CR3) 1994; 63 X Li (1452_CR22) 1642; 2016 IC Chou (1452_CR50) 2010; 24 CC Chio (1452_CR56) 2015; 22 L Xu (1452_CR40) 2016; 53 S Moorlag (1452_CR51) 2018; 281 O Giorgi (1452_CR30) 1991; 193 J Vinet (1452_CR32) 2016; 64 A Cianciulli (1452_CR36) 2015; 24 T Ravizza (1452_CR7) 2006; 24 E Aronica (1452_CR6) 2007; 26 C Roseti (1452_CR20) 2013; 54 J Palomo (1452_CR52) 2015; 76 Y Youn (1452_CR58) 2013; 56 AS Yazdi (1452_CR44) 2010; 107 A Vezzani (1452_CR49) 2008; 22 Z Zhang (1452_CR11) 2008; 65 AH Haas de (1452_CR33) 2007; 55 A Vezzani (1452_CR39) 2011; 7 AM Bhandare (1452_CR57) 2015; 35 MD Nguyen (1452_CR12) 2002; 3 TA Siddiqui (1452_CR54) 2016; 13 |
References_xml | – volume: 193 start-page: 363 year: 1991 ident: 1452_CR30 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(91)90152-G – volume: 60 start-page: 173 year: 2017 ident: 1452_CR55 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2017.08.022 – volume: 6 start-page: a022699 year: 2015 ident: 1452_CR46 publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a022699 – volume: 13 start-page: 66 year: 2016 ident: 1452_CR54 publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0531-9 – volume: 49 start-page: 66 year: 2015 ident: 1452_CR23 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2015.04.063 – volume: 46 start-page: 1724 year: 2005 ident: 1452_CR2 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2005.00298.x – volume: 180 start-page: 7827 year: 2008 ident: 1452_CR28 publication-title: J Immunol doi: 10.4049/jimmunol.180.12.7827 – volume: 7 start-page: 31 year: 2011 ident: 1452_CR39 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.178 – volume: 3 start-page: 216 year: 2002 ident: 1452_CR12 publication-title: Nat Rev Neurosci doi: 10.1038/nrn752 – volume: 56 start-page: 991 year: 2015 ident: 1452_CR14 publication-title: Epilepsia doi: 10.1111/epi.13100 – volume: 63 start-page: 1872 year: 1994 ident: 1452_CR3 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1994.63051872.x – volume: 66 start-page: 972 year: 2014 ident: 1452_CR10 publication-title: Pharmacol Rep doi: 10.1016/j.pharep.2014.06.005 – volume: 55 start-page: 1374 year: 2007 ident: 1452_CR33 publication-title: Glia doi: 10.1002/glia.20554 – volume: 13 start-page: 270 year: 2016 ident: 1452_CR48 publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0727-z – volume: 107 start-page: 163 year: 2012 ident: 1452_CR8 publication-title: Handb Clin Neurol doi: 10.1016/B978-0-444-52898-8.00010-0 – volume: 282 start-page: 110 year: 2015 ident: 1452_CR13 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2015.04.003 – volume: 38 start-page: 666 year: 2016 ident: 1452_CR35 publication-title: Int J Mol Med doi: 10.3892/ijmm.2016.2656 – volume: 14 start-page: 279 year: 2003 ident: 1452_CR5 publication-title: Neurobiol Dis doi: 10.1016/S0969-9961(03)00127-X – volume: 51 start-page: 34 issue: Suppl 3 year: 2010 ident: 1452_CR47 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2010.02606.x – volume: 24 start-page: 154 year: 2010 ident: 1452_CR50 publication-title: J Clin Lab Anal doi: 10.1002/jcla.20374 – volume: 18 start-page: 221 year: 2018 ident: 1452_CR27 publication-title: BMC Complement Altern Med doi: 10.1186/s12906-018-2287-5 – volume: 7 start-page: 2583 year: 2012 ident: 1452_CR31 publication-title: Int J Nanomedicine doi: 10.2147/IJN.S31050 – volume: 54 start-page: 1834 year: 2013 ident: 1452_CR20 publication-title: Epilepsia doi: 10.1111/epi.12354 – volume: 28 start-page: 6904 year: 2008 ident: 1452_CR25 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1901-08.2008 – volume: 10 start-page: 241 year: 2009 ident: 1452_CR43 publication-title: Nat Immunol doi: 10.1038/ni.1703 – volume: 32 start-page: 593 year: 2010 ident: 1452_CR17 publication-title: Immunity doi: 10.1016/j.immuni.2010.05.007 – volume: 27 start-page: 3013 year: 2009 ident: 1452_CR41 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.03.034 – volume: 2 start-page: 76 year: 2017 ident: 1452_CR1 publication-title: Epilepsia Open doi: 10.1002/epi4.12036 – volume: 36 start-page: 68 year: 2014 ident: 1452_CR59 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2014.04.009 – volume: 9 start-page: 126 year: 2012 ident: 1452_CR34 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-9-126 – volume: 107 start-page: 19449 year: 2010 ident: 1452_CR44 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1008155107 – volume: 65 start-page: 4055 year: 2008 ident: 1452_CR11 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-008-8521-4 – volume: 7 start-page: 9585 year: 2013 ident: 1452_CR26 publication-title: ACS Nano doi: 10.1021/nn404473g – volume: 24 start-page: 369 year: 2015 ident: 1452_CR36 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2014.12.035 – volume: 281 start-page: 36560 year: 2006 ident: 1452_CR38 publication-title: J Biol Chem doi: 10.1074/jbc.M607594200 – volume: 76 start-page: 25 year: 2015 ident: 1452_CR52 publication-title: Cytokine doi: 10.1016/j.cyto.2015.06.017 – volume: 24 start-page: 128 year: 2006 ident: 1452_CR7 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2006.06.003 – volume: 22 start-page: 797 year: 2008 ident: 1452_CR49 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2008.03.009 – volume: 19 start-page: 5054 year: 1999 ident: 1452_CR9 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.19-12-05054.1999 – volume: 6 start-page: 193 year: 2010 ident: 1452_CR15 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.17 – volume: 53 start-page: 6709 year: 2016 ident: 1452_CR40 publication-title: Mol Neurobiol doi: 10.1007/s12035-015-9593-4 – volume: 281 start-page: 28 year: 2018 ident: 1452_CR51 publication-title: Immunol Rev doi: 10.1111/imr.12617 – volume: 29 start-page: 249 year: 2007 ident: 1452_CR45 publication-title: Semin Immunopathol doi: 10.1007/s00281-007-0085-0 – volume: 26 start-page: 497 year: 2007 ident: 1452_CR6 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2007.01.015 – volume: 94 start-page: 416 year: 2010 ident: 1452_CR29 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2009.10.003 – volume: 22 start-page: 759 year: 2015 ident: 1452_CR56 publication-title: Curr Med Chem doi: 10.2174/0929867321666141106124657 – volume: 64 start-page: 1350 year: 2016 ident: 1452_CR32 publication-title: Glia doi: 10.1002/glia.23008 – volume: 28 start-page: 9133 year: 2008 ident: 1452_CR18 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1820-08.2008 – volume: 481 start-page: 278 year: 2012 ident: 1452_CR42 publication-title: Nature doi: 10.1038/nature10759 – volume: 89 start-page: 34 year: 2010 ident: 1452_CR24 publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2009.09.004 – volume: 35 start-page: 2191 year: 2015 ident: 1452_CR57 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4058-14.2015 – volume: 8 start-page: 304 year: 2011 ident: 1452_CR53 publication-title: Neurotherapeutics doi: 10.1007/s13311-011-0039-z – volume: 56 start-page: 271 year: 2013 ident: 1452_CR58 publication-title: Korean J Pediatr doi: 10.3345/kjp.2013.56.7.271 – volume: 13 start-page: 85 year: 2016 ident: 1452_CR19 publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0546-2 – volume: 224 start-page: 22 year: 2010 ident: 1452_CR21 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2010.05.016 – volume: 952 start-page: 159 year: 2002 ident: 1452_CR4 publication-title: Brain Res doi: 10.1016/S0006-8993(02)03050-0 – volume: 4 start-page: 399 year: 2009 ident: 1452_CR16 publication-title: J NeuroImmune Pharmacol doi: 10.1007/s11481-009-9164-4 – volume: 2016 start-page: 487 year: 1642 ident: 1452_CR22 publication-title: Brain Res – volume: 30 start-page: 556 year: 2009 ident: 1452_CR37 publication-title: Immunity doi: 10.1016/j.immuni.2009.02.005 |
SSID | ssj0032562 |
Score | 2.5449998 |
Snippet | Background
Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β... Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β secreted by... Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and IL-1β... Abstract Background Microglia are important for secreting chemical mediators of inflammatory responses in the central nervous system. Interleukin (IL)-10 and... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 66 |
SubjectTerms | Animals Autocrine signalling Biomedical and Life Sciences Biomedicine Brain - pathology Brain research Caspase Caspase-1 Cell adhesion & migration Cells, Cultured Central nervous system Convulsants - toxicity Convulsions & seizures Cytokines Cytokines - genetics Cytokines - metabolism Disease Disease Models, Animal Encephalopathy Enzyme-linked immunosorbent assay Epilepsy Flow cytometry Gene Expression Regulation - drug effects Glial cells IL-10 IL-1β Immunology Inflammasomes Inflammation Interleukin 10 Interleukin-10 - pharmacology Interleukin-1beta - metabolism Lipopolysaccharides Lipopolysaccharides - toxicity Male Mice Mice, Inbred C57BL Microglia Microglia - drug effects Microglia - metabolism Nervous system Neurobiology Neurology Neuronal-glial interactions Neurosciences Nucleic Acids - genetics Nucleic Acids - metabolism Picrotoxin Picrotoxin - toxicity Polyclonal antibodies Polymerase chain reaction Reverse transcription RNA, Small Interfering - pharmacology Seizures Seizures - chemically induced Seizures - metabolism Seizures - pathology Signal Transduction - drug effects Signal Transduction - genetics Stat3 protein STAT3 Transcription Factor - metabolism Tumor necrosis factor-TNF Western blotting |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s1CQUbiBLLq9-MIiKpCghOVerP8Co3YzS5k98LP6g_pb2KcZJcuzwu3yJ441sx4PJ9nMkbouQwW0LFiRAhNiSyFkmhZISnCo41CxTBU-_ygT07luzN1duWqr5oTNpYHHhl3VMDhNsllLhyTKomokgZMk7KxqSiWqvWljm7B1GiDBWzkfIphMquPetjVTM22cAQG4YTt7UJDsf7feZi_Jkr-FC0dNqHjW-jm5D3iV-Osb6NrpbuDrr-f4uN30ZfhgG9eNp_bDkwfbrvzNrbrHrdX2y8v8Gos9ApCwaHL0N2AZixCv1wUXH91GA9q8bLBi5qx92neBiDCZQVGBIxMwn1pv20Aqt9Dp8dvP745IdOlCiQpoddEORdKY2MxNCfbAFoLylkTbWZJD9fW6MJ5E0yJMakkQ1LKZi1EwxvlpBL30UG37MpDhGk0JTTS2WyojCxEqVXOAVwSYUKTzQzRLZN9miqO14sv5n5AHlb7US4e5OKrXDyboRe7V1ZjuY2_Eb-uktsR1krZQwPoj5_0x_9Lf2bocCt3Py3f3nOAxRLAnoZvPNt1w8Kr0ZTQleWm0lT3SlvlZujBqCa7mQjqwO0SfIbMngLtTXW_p2vPh-LeNZDqGIz5cqtqP6b1R048-h-ceIxu8LpCqCDcHqKD9ddNeQIe1zo-HRbXd2kKKU4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3JbtQw1IIiIS6IvSkFGYkTyGoc7ycEiKpCghOV5hZ5Sxsxk0ybmQuf1Q_hm3h2MlOGpbfIfo4cv8Vvy3sIveZWg3UsKGFMloTHWBKnaSTewaN2TDibq31-lSen_PNMzCaH2zClVW5kYhbUoffJR35UgaXCQf-W9N3ygqSuUSm6OrXQuI3uUNBEUusGNdsaXAyu82qKZFItjwa421TKuTCEclERunMX5ZL9_9Iz_06X_CNmmq-i4wfo_qRD4vcj0h-iW7F7hO5-maLkj9FFdvPN4_p724EAxG133rp2NeD29_GfV3g5lnsF1GDbBZhugD4WdugXEacfHkZ3Le4bvEh5e2fz1gIQjksQJSBqPB5i-2MNBvsTdHr86dvHEzK1ViBeMLkiwhgbG-2iKoPXDdhsVhitnA7Uy9y8RsaqaqyKznnhufVC6CAZa6pGGC7YU7TX9V3cR7h0KtqGGx1UyR21jksRggXFhCnbBFWgcnPItZ_qjqf2F_M62x9a1iNeasBLnfBS0wK92S5ZjkU3bgL-kDC3BUz1svNAf3lWT-xXRzDblDehYgZWeeaEl2AZ-6C0j4L6Ah1u8F5PTDzU1yRXoFfbaWC_FFOxXezXCSYpWVILU6BnI5lsd8JKA8oXqwqkdghoZ6u7M117nkt8p3CqofDOtxtSu97Wf0_i4OaPeI7uVYn2S0YqfYj2Vpfr-AI0qpV7mdnmF1jlIOg priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkRAXxJtAQUbiBLJI_PYRVlQVEpyo1JvlV2jEbnZLdi_8rP6Q_ibGTnbpQkHiFsXjxPI8P489RugVdxrQsWgIY7ImPKWaeN0kEjw8as-Ed6Xa52d5fMI_norTqVh0PgtzNX_faPl2AH-k8j4JQxouKAGgc1OA3c3CPJOzrdFl4LnplLS8ttue2ynV-a8LKf_cGflberR4naO76M4ULuJ3I3_voRupv49ufZoS4g_QeVnRm6fNt64HW4e7_qzz3XrA3dX3lxd4NVZ2BS5g10dobkEUFm5YLhLOZxvGlVm8bPEib9H7Ou8cEOG0AqsBViXgIXU_NoDNH6KTow9fZsdkukWBBMHkmghjXGq1T6qOQbcAz5wwWnkdmyDLPTUyUdo6lbwPInAXhNBRMtbSVhgu2CN00C_79ATh2qvkWm50VDX3jfNcihgdxCBMuTaqCtXbSbZhKjGeb7qY2wI1tLQjXyzwxWa-2KZCr3ddVmN9jX8Rv8-c2xHm0tjlBUiMnTTNJkBoKphImYFegXkRJIDgEJUOSTShQodbvttJXwdLAQdzQHcS_vFy1wyaltMnrk_LTabJ8ZTUwlTo8Sgmu5Gw2kCcxWiF1J4A7Q11v6Xvzko175w5NQ18881W1H4N668z8fS_qJ-h2zSrQs0I1YfoYP19k55DLLX2L4oW_QSePRl7 priority: 102 providerName: Springer Nature |
Title | Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures |
URI | https://link.springer.com/article/10.1186/s12974-019-1452-1 https://www.ncbi.nlm.nih.gov/pubmed/30922332 https://www.proquest.com/docview/2211408661 https://www.proquest.com/docview/2200786859 https://pubmed.ncbi.nlm.nih.gov/PMC6437919 https://doaj.org/article/e2607c9d239145c3b5c6549cd78ce51c |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbGJiFeEHfKRmUknkCBJL4_INRVm6ZKTAio1LfIdpwtok26XqTBz-KH8Js4dtJAofDEUyr7OLHOxT6fj3sOQs-ploCOWRIRwuOIOhdHRiYusgZ-SkOY0SHb5zk_G9PRhE320Ka8VcvA5U5o5-tJjRfTV9dXX96Cwb8JBi_56yXsWcLfpVBRQlkaARg6COEif5OPdkEFArt72gY2dw7b2ppCBv9dbueftyd_C6GGnen0DrrdupR40OjAXbTnqnvo5rs2aH4fXYVTv6lbfy4rWA9xWV2Wplwtcflr-_dveN5kfwVJYV3l0F2Ausz0sp457P__0Jze4rrAM3-N72JaaiDCbg4rC6w8Fi9d-XUN-P0BGp-efBqeRW2lhcgywlcRU0q7Qhon4tzKAiCcZkoKI_PE8lDLhrs0LbRwxlhmqbaMyZwTUqQFU5SRh2i_qiv3GOHYCKcLqmQuYmoSbShnea7BTyFCF7nooXjD5My2ach9NYxpFuCI5Fkjlwzkknm5ZEkPveiGzJscHP8iPvaS6wh9-uzQUC8ustYaMwcoTliVp0TBKEsMsxyAss2FtI4ltoeONnLPNiqZpYCVKSBADt941nWDNfoQi65cvfY03ufikqkeetSoSTcTEivwxUjaQ2JLgbamut1TlZch47ePrqoE3vlyo2o_p_VXTjz5H5w4RLdSbyExiVJ5hPZXi7V7Cm7YyvTRDTERfXQwGIw-juB5fHL-_gO0DvmwH442-sH8fgDeWTbA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0KpaCbgg3g0UMBJcQFFjO3acQ4UotNrSdoVQK_UW_EobsZtsN7tC8Fl8AJ_ANzHOY8vy6K23yJ5Ejmc8b88g9DxWEqxjTkLGRBTGzkWhlsSFRsOj1Ixr1VT7HIrBcfz-hJ-soB_9XRifVtnzxIZR28p4H_kmBUslBv1bkNeT89B3jfLR1b6FhupaK9itpsRYd7Fj3339AiZcvbX3DvD9gtLdnaO3g7DrMhAazsQs5GmqXC61SyJrZA7mi-JgiGtpiRFNHxfhKM1V4rQ23MTKcC6tYCynOU9j3zUCRMBa7B0oq2hte2f44WMvCxgoFLSLpRIpNmuQronP-khDEnMakiVp2DQN-Jem-3fC5h9R20YY7t5CNzstFr9pye42WnHlHXTtsIvT30XnjaNx5OafixJYMC7Ks0IXsxoXv4___I4nbcFZIA6sSgvTOVDoWNXV2GF_5aJ1GOMqx2OfOXg6KhQAYTcBZgbMzuDaFd_mU1ffQ8dXsu330WpZlW4d4UgnTuVxKm0SxZooHQturQLViCUqt0mAon6TM9NVPvcNOEZZYwFJkbV4yQAvmcdLRgL0cvHKpC37cRnwtsfcAtBX7G4Gqulp1jGAzIHhmJjUUpbCW4ZpbgTY5sYm0jhOTIA2erxnHRupswuiD9CzxTQwAB_VUaWr5h7Gq3lC8jRAD1oyWayERSmof4wGKFkioKWlLs-UxVlTZNwHdFMC33zVk9rFsv67Ew8v_4mn6Prg6PAgO9gb7j9CN6g_BxELqdxAq7Pp3D0G_W6mn3SHCKNPV31ufwE6umTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQK1VcEG9CCxiJEyhqYsev4_JYlQUqJKjUm-VX2ojdZGl2L_1Z_BB-E-M8FhYKErcoHieWZ8Yzn2c8RuhZYSSgY5anlPIsLULIUivzkDoLj9JSZk1X7fOYH50Us1N2Otxz2o7Z7mNIsj_TEKs01avDpS97FZf8sAUrJWL2hErzgpEU4M-uZEoB-tqdTGafZuNiTMGikyGYeWXHLXPUVe2_ytX8M2Pyt7BpZ42mN9GNwY3Ek57vt9C1UN9Gex-GQPkd9LXb6ZuH9ZeqhjUQV_V5ZatVi6tf33__hpd9xVfgDja1h-YSRGRh2mYRcDzz0O_Y4qbEi5i6dzavDBDhsITVBFYbh9tQXa4Bs99FJ9M3n18dpcPtCqljlK9SmC4TSmmDyLyTJcA2w5QUVvrc8e7-Gh4IKY0I1jrmCuMYk55TWpKSqYLRe2inburwAOHMimDKQkkvssLmxhaceW_AN6HClF4kKBsnWbuh9Hi8AWOuOwgiue75ooEvOvJF5wl6vumy7Otu_Iv4ZeTchjCWzO5eNBdnetBAHQC5Cac8oQp6OWqZ4wCOnRfSBZa7BB2MfNeDHreaAD4uAPVx-MfTTTNoYAyrmDo060gT_SwO8peg-72YbEZCMwX-FyUJElsCtDXU7Za6Ou-qfMeIqsrhmy9GUfs5rL_OxMP_on6C9j6-nur3b4_f7aPrJGpFRlMiD9DO6mIdHoG7tbKPB5X6AQAcJig |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-10+inhibits+interleukin-1%CE%B2+production+and+inflammasome+activation+of+microglia+in+epileptic+seizures&rft.jtitle=Journal+of+neuroinflammation&rft.au=Yi+Sun&rft.au=Jiangjun+Ma&rft.au=Dongfang+Li&rft.au=Pinggan+Li&rft.date=2019-03-28&rft.pub=BMC&rft.eissn=1742-2094&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1186%2Fs12974-019-1452-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e2607c9d239145c3b5c6549cd78ce51c |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon |